admin

admin
Bitcoin

Royal Bank of Canada stock double-tops ahead of Q1 earnings

Royal Bank of Canada stock has been in an unstoppable bull run in the past few years and is now hovering at its

Read More
Bitcoin

Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

Millions of people on GLP-1 weight-loss drugs know the weekly routine by heart: a new injector pen, a new box, another reminder to

Read More
Business

ETH eyes further dip as Buterin looks to sell more holdings

The cryptocurrency market opened the new weekly candle bearish, as Bitcoin, Ether, and XRP tested key support levels. Ether, the second-largest cryptocurrency by

Read More
Business

Citrini research: S&P 500 to drop 38% from 2026 highs by June 2028

In a sweeping and provocative macro-analysis titled “The 2028 Global Intelligence Crisis,” Citrini Research has outlined a sobering vision of a financial future

Read More
Business

Why is Arcellx stock up 80% today? Gilead’s $7.8B answer

Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a

Read More
Business

South Korea debates bank control over won stablecoins

South Korea’s stablecoin framework is facing renewed scrutiny as the country’s central bank urges lawmakers to keep control of won-pegged digital tokens within

Read More
Business

Finland’s IQM leads Europe’s quantum push with US listing plan

Finland’s IQM is positioning itself at the centre of Europe’s quantum technology ambitions as it prepares to enter public markets in the US.

Read More
Business

We predicted the Blue Owl stock price crash to $10

Blue Owl stock price has crashed in the past few months, turning one of the most blue-chip financial giants into a fallen angel.

Read More
Business

Trump tariffs repriced after SCOTUS ruling: winners and losers

Fridays used to be reserved for routine headlines. But since Donald Trump’s reelection, every Friday seems like a bombshell day. And last Friday

Read More
Business

Merck creates separate oncology arm ahead of Keytruda patent loss

Merck said on Monday that it will split its human-health operations into two separate divisions, a move designed to sharpen focus across its

Read More